Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia.

scientific article published on 28 May 2013

Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/PCN.12056
P698PubMed publication ID23711166
P5875ResearchGate publication ID236947629

P2093author name stringHiroto Ito
Atsushi Nishida
Toshie Noda
Junichi Fujita
Mutsumi Sakata
P2860cites workMental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.Q51906290
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.Q51942046
'As required' medication regimens for seriously mentally ill people in hospitalQ24243947
The subjective experience of taking antipsychotic medication: a content analysis of Internet dataQ33409973
Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.Q34447495
Schizophrenia, neuroleptic medication and mortalityQ34490208
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinationsQ34941330
PRN psychotropic medications: the need for nursing researchQ35179992
P.R.N. (As-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medicationsQ35211386
Benzodiazepines in the treatment of schizophrenia: a review and reappraisalQ36495525
Management of agitation in the acute psychotic patient--efficacy without excessive sedationQ36751058
A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settingsQ37139818
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribingQ37178857
Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challengesQ37326610
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosesQ39465776
An epidemiologic study of prn/stat medication use in a state psychiatric hospitalQ40942225
Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nursesQ44133348
A study of psychotropic medication given 'as required' in a regional secure unitQ44548496
Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.Q44695401
Use of pro re nata medications in acute inpatient care.Q46710247
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapyQ46901295
Administration of 'as needed' psychotropic medication: a retrospective studyQ48407624
Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings: a Delphi study.Q51901453
P433issue5
P921main subjectschizophreniaQ41112
P1104number of pages7
P304page(s)345-351
P577publication date2013-05-28
P1433published inPsychiatry and Clinical NeurosciencesQ15760564
P1476titleExcessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia.
P478volume67

Reverse relations

cites work (P2860)
Q42707831Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy.
Q48492684Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits
Q48059796Exploring the response shift effect on the quality of life of patients with schizophrenia: an application of the random forest method
Q39062177Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward
Q38880399Nurses' attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings
Q58692770Patient Safety and Prescription and Administration: A Systematic Review
Q38239613Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy